STOCK TITAN

[Form 4] Ceribell, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Ceribell, Inc. filed a Form 4 reporting recent stock transactions by its Chief Technology Officer. On 11/20/2025, 687 shares of common stock were withheld or disposed of at $13.64 in a transaction coded “F,” typically used for tax withholding.

On 01/02/2026, the CTO exercised multiple stock options and immediately sold the resulting shares in pre-planned trades under a Rule 10b5-1 trading plan. Options with exercise prices of $2.24 and $4.70 were exercised in blocks of 1,472, 3,025 and 6,615 shares, followed by sales coded “S” at weighted-average prices of $21.29, $21.18 and $21.16.

After these transactions, the reporting person beneficially owned 167,317 shares of Ceribell common stock, which includes 300 shares acquired through the company’s employee stock purchase plan. The filing also notes outstanding stock options that are vested or continue to vest over time, extending to expiration dates in 2029 and 2033.

Positive

  • None.

Negative

  • None.
Insider Woo Raymond
Role Chief Technology Officer
Sold 11,112 shs ($235K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 1,472 $0.00 --
Exercise Stock Option (Right to Buy) 3,025 $0.00 --
Exercise Stock Option (Right to Buy) 6,615 $0.00 --
Exercise Common Stock 1,472 $2.24 $3K
Sale Common Stock 1,472 $21.29 $31K
Exercise Common Stock 3,025 $4.70 $14K
Sale Common Stock 3,025 $21.18 $64K
Exercise Common Stock 6,615 $4.70 $31K
Sale Common Stock 6,615 $21.16 $140K
Tax Withholding Common Stock 687 $13.64 $9K
Holdings After Transaction: Stock Option (Right to Buy) — 14,274 shares (Direct); Common Stock — 168,789 shares (Direct)
Footnotes (1)
  1. Includes 300 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2025. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.75 to $21.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.75 to $21.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.76 to $21.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. The option vests with respect to 1/24 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Woo Raymond

(Last) (First) (Middle)
C/O CERIBELL, INC.
360 N. PASTORIA AVENUE

(Street)
SUNNYVALE CA 94085

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Technology Officer
3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/20/2025 F 687 D $13.64 167,317(1) D
Common Stock 01/02/2026 M(2) 1,472 A $2.24 168,789 D
Common Stock 01/02/2026 S(2) 1,472 D $21.29(3) 167,317 D
Common Stock 01/02/2026 M(2) 3,025 A $4.7 170,342 D
Common Stock 01/02/2026 S(2) 3,025 D $21.18(4) 167,317 D
Common Stock 01/02/2026 M(2) 6,615 A $4.7 173,932 D
Common Stock 01/02/2026 S(2) 6,615 D $21.16(5) 167,317 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $2.24 01/02/2026 M(2) 1,472 (6) 06/10/2029 Common Stock 1,472 $0 14,274 D
Stock Option (Right to Buy) $4.7 01/02/2026 M(2) 3,025 (7) 02/16/2033 Common Stock 3,025 $0 44,796 D
Stock Option (Right to Buy) $4.7 01/02/2026 M(2) 6,615 (8) 02/16/2033 Common Stock 6,615 $0 45,523 D
Explanation of Responses:
1. Includes 300 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2025.
2. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.75 to $21.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.75 to $21.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.76 to $21.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
6. The stock option is fully vested and currently exercisable.
7. The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
8. The option vests with respect to 1/24 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
/s/ Louisa Daniels, Attorney-in-Fact for Raymond Woo 01/06/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Ceribell (CBLL) Form 4 filing disclose?

The Form 4 shows that Ceribell’s Chief Technology Officer exercised stock options and sold shares in several transactions, and reports his updated beneficial ownership in company stock.

Who is the insider involved in these Ceribell (CBLL) transactions?

The transactions involve Ceribell’s Chief Technology Officer, who is an officer of the company and therefore required to report trades in the company’s equity securities.

What stock transactions did the Ceribell CTO report on November 20, 2025?

On 11/20/2025, the CTO reported a transaction coded “F” involving 687 shares of common stock at a price of $13.64, which typically reflects shares withheld or disposed of for tax purposes.

What option exercises and stock sales occurred on January 2, 2026 for CBLL?

On 01/02/2026, the CTO exercised stock options with exercise prices of $2.24 and $4.70 in blocks of 1,472, 3,025 and 6,615 shares, then sold the resulting shares at weighted-average prices of $21.29, $21.18 and $21.16.

How many Ceribell (CBLL) shares does the CTO own after these trades?

Following the reported transactions, the CTO beneficially owned 167,317 shares of Ceribell common stock, including 300 shares acquired under the company’s employee stock purchase plan.

Were the Ceribell CTO’s trades made under a Rule 10b5-1 trading plan?

Yes. The filing states that the transactions were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

What do the vesting terms of the Ceribell CTO’s stock options look like?

One option grant is fully vested and currently exercisable. Other options vest in equal installments on each monthly anniversary of April 1, 2023, over 48 or 24 months, subject to continued employment or service.